Chapter/Section Purchase

1 Study Coverage
1.1 Antibiotics Active Pharmaceutical Ingredient (API) Product Introduction
1.2 Market by Type
1.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Penicillin Antibiotics
1.2.3 Cephalosporins
1.2.4 Carbapenem Antibiotics
1.3 Market by Application
1.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Estimates and Forecasts 2017-2028
2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
2.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2017-2022)
2.4.2 Global Sales Antibiotics Active Pharmaceutical Ingredient (API) by Region (2023-2028)
2.5 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region
2.5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2022)
2.5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Manufacturers
3.1.1 Global Top Antibiotics Active Pharmaceutical Ingredient (API) Manufacturers by Sales (2017-2022)
3.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibiotics Active Pharmaceutical Ingredient (API) in 2021
3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Manufacturers
3.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibiotics Active Pharmaceutical Ingredient (API) Revenue in 2021
3.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type
4.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Historical Sales by Type (2017-2022)
4.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2017-2028)
4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type
4.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Historical Revenue by Type (2017-2022)
4.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2017-2028)
4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type
4.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2017-2022)
4.3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application
5.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Historical Sales by Application (2017-2022)
5.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2017-2028)
5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application
5.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Historical Revenue by Application (2017-2022)
5.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2017-2028)
5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application
5.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2017-2022)
5.3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
6.1.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
6.1.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
6.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
6.2.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
6.2.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
6.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
6.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2017-2028)
6.3.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
7.1.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
7.1.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
7.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
7.2.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
7.2.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
7.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
7.3.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2017-2028)
7.3.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
8.1.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
8.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
8.2.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
8.3 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region
8.3.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
9.1.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
9.1.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
9.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
9.2.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
9.2.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
9.3 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
9.3.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2017-2028)
9.3.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
10.1.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
10.2.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
10.3.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sandoz International
11.1.1 Sandoz International Corporation Information
11.1.2 Sandoz International Overview
11.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sandoz International Recent Developments
11.2 Centrient Pharmaceuticals
11.2.1 Centrient Pharmaceuticals Corporation Information
11.2.2 Centrient Pharmaceuticals Overview
11.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Centrient Pharmaceuticals Recent Developments
11.3 CordenPharma International
11.3.1 CordenPharma International Corporation Information
11.3.2 CordenPharma International Overview
11.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CordenPharma International Recent Developments
11.4 ACS DOBFAR
11.4.1 ACS DOBFAR Corporation Information
11.4.2 ACS DOBFAR Overview
11.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 ACS DOBFAR Recent Developments
11.5 Nanjing Dorra Pharmaceutical Technology
11.5.1 Nanjing Dorra Pharmaceutical Technology Corporation Information
11.5.2 Nanjing Dorra Pharmaceutical Technology Overview
11.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments
11.6 DAEWOONG PHARMACEUTICAL
11.6.1 DAEWOONG PHARMACEUTICAL Corporation Information
11.6.2 DAEWOONG PHARMACEUTICAL Overview
11.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DAEWOONG PHARMACEUTICAL Recent Developments
11.7 Parabolic Drugs
11.7.1 Parabolic Drugs Corporation Information
11.7.2 Parabolic Drugs Overview
11.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Parabolic Drugs Recent Developments
11.8 Penam Laboratories
11.8.1 Penam Laboratories Corporation Information
11.8.2 Penam Laboratories Overview
11.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Penam Laboratories Recent Developments
11.9 ASIATIC DRUGS & PHARMACEUTICALS
11.9.1 ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
11.9.2 ASIATIC DRUGS & PHARMACEUTICALS Overview
11.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments
11.10 Fresenius Kabi
11.10.1 Fresenius Kabi Corporation Information
11.10.2 Fresenius Kabi Overview
11.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fresenius Kabi Recent Developments
11.11 The United Laboratories International Holdings
11.11.1 The United Laboratories International Holdings Corporation Information
11.11.2 The United Laboratories International Holdings Overview
11.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 The United Laboratories International Holdings Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Corporation Information
11.12.2 Aurobindo Pharma Overview
11.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aurobindo Pharma Recent Developments
11.13 Unimark Remedies
11.13.1 Unimark Remedies Corporation Information
11.13.2 Unimark Remedies Overview
11.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Unimark Remedies Recent Developments
11.14 Savior Lifetec
11.14.1 Savior Lifetec Corporation Information
11.14.2 Savior Lifetec Overview
11.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Savior Lifetec Recent Developments
11.15 Shenzhen Haibin Pharmaceutical
11.15.1 Shenzhen Haibin Pharmaceutical Corporation Information
11.15.2 Shenzhen Haibin Pharmaceutical Overview
11.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shenzhen Haibin Pharmaceutical Recent Developments
11.16 Sterile India
11.16.1 Sterile India Corporation Information
11.16.2 Sterile India Overview
11.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sterile India Recent Developments
11.17 Zhejiang Jiuzhou Pharmaceutical
11.17.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
11.17.2 Zhejiang Jiuzhou Pharmaceutical Overview
11.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
11.18 Kyongbo Pharm
11.18.1 Kyongbo Pharm Corporation Information
11.18.2 Kyongbo Pharm Overview
11.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Kyongbo Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Chain Analysis
12.2 Antibiotics Active Pharmaceutical Ingredient (API) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibiotics Active Pharmaceutical Ingredient (API) Production Mode & Process
12.4 Antibiotics Active Pharmaceutical Ingredient (API) Sales and Marketing
12.4.1 Antibiotics Active Pharmaceutical Ingredient (API) Sales Channels
12.4.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors
12.5 Antibiotics Active Pharmaceutical Ingredient (API) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends
13.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Drivers
13.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
13.4 Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
14 Key Findings in The Global Antibiotics Active Pharmaceutical Ingredient (API) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer